Last reviewed · How we verify
to evaluate the association of gucy1a3 rs7692387 gene polymorphism carrier on the development of cardiovascular events after coronary artery bypass grafting
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- to evaluate the association of gucy1a3 rs7692387 gene polymorphism carrier on the development of cardiovascular events after coronary artery bypass grafting patent landscape — cliff calendar, originator estates, attackable patents
- to evaluate the association of gucy1a3 rs7692387 gene polymorphism carrier on the development of cardiovascular events after coronary artery bypass grafting treatment landscape brief
- to evaluate the association of gucy1a3 rs7692387 gene polymorphism carrier on the development of cardiovascular events after coronary artery bypass grafting treatment updates RSS
Related
- Treatment landscape: to evaluate the association of gucy1a3 rs7692387 gene polymorphism carrier on the development of cardiovascular events after coronary artery bypass grafting patent cliff · to evaluate the association of gucy1a3 rs7692387 gene polymorphism carrier on the development of cardiovascular events after coronary artery bypass grafting CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing